Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Once-weekly SYR-472 treatment produced clinically and statistically significant improvements in glycaemic control in patients with type 2 diabetes
Smiles: CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC1C=CC=CC=1)NC(=O)[C@H](CC(N)=O)NC(=O)C1=CC=C2C=CC=CC2=N1
) enhances the mean survival time of the tumor bearing Swiss albino mice
24 hours) treatment directly enhances IL-10 production and suppresses IL-12/23p40 production in primary peritoneal macrophages with IFN-γ stimulation
is a potent and selective rabies virus (RABV) entry inhibitor with nanomolar potency against some RABV strains
PSB 1115 ubitrilat Once-weekly SYR-472 treatment produced clinicallyProduct information CAS Number: 152529 79 8 Molecular Weight: 350. 35 Formula: C14H14N4O5S Chemical Name: 4 (2,6 dioxo 1 propyl 2,3,6,7 tetrahydro 1H purin 8 yl)benzene 1 sulfonic acid Smiles: CCCN1C(=O)C2NC(=NC=2NC1=O)C1C=CC(=CC=1)S(O)(=O)=O InChiKey: UYDRRQPGDSIMNU UHFFFAOYSA N InChi: InChI=1S C14H14N4O5S c1 2 7 18 13(19)10 12(17 14(18)20)16 11(15 10)8 3 5 9(6 4 8)24(21,22)23 h3 6H,2,7H2,1H3,(H,15,16)(H,17,20)(H,21,22,23) Technical Data Appearance:
US$ 38.00
US$ 38.00
US$ 45.00
US$ 95.00
US$ 90.00
US$ 90.00
US$ 150.00
US$ 38.00
US$ 36.00
US$ 40.95
US$ 44.00
US$ 38.00